1. Center for inflammatory skin diseases, Department of Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany;
2. Department of Dermatology, University of Essen, Essen, Germany;
3. Novartis Pharma GmbH, Nürnberg, Germany;
4. Novartis Pharma AG, Basel, Switzerland